Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765602What this trial is testingRusfertide in Adults With Polycythemia Vera in ChinaWho this might be right forPolycythemia Vera Takeda 24
Not applicableStudy completedNCT03971253What this trial is testingJapan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis (RA) Astellas Pharma Inc 3,000
Early research (Phase 1)Study completedNCT03213145What this trial is testingDrug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy VolunteersWho this might be right forNASH - Nonalcoholic Steatohepatitis Enanta Pharmaceuticals, Inc 48
Testing effectiveness (Phase 2)Study completedNCT02193139What this trial is testingSafety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary HyperhidrosisWho this might be right forHyperhidrosis Watson Pharmaceuticals 195
Not applicableStudy completedNCT01895712What this trial is testingBIOFLOW-III Israel Satellite RegistryWho this might be right forCoronary Artery DiseaseMyocardial IschemiaDiabetes Mellitus Type 1 or 2 BIOTRONIK Israel 120
Testing effectiveness (Phase 2)Study completedNCT01779453What this trial is testingThe Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With HypercholesterolemiaWho this might be right forHypercholesterolemia Esperion Therapeutics, Inc. 58
Early research (Phase 1)Study completedNCT05376345What this trial is testingBCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple MyelomaWho this might be right forRelapsed/Refractory Multiple Myeloma Shanghai Changzheng Hospital 24
Testing effectiveness (Phase 2)Study completedNCT03520972What this trial is testingDose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM SubjectsWho this might be right forType 2 Diabetes Mellitus PegBio Co., Ltd. 251
Early research (Phase 1)Study completedNCT00000772What this trial is testingA Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive IndividualsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 15
Not applicableLooking for participantsNCT06922669What this trial is testingGlucocorticoids for Acute Drug Induced Liver Injury With HyperbilirubinemiaWho this might be right forDrug Induced Liver Injury General Hospital of Shenyang Military Region 232
Early research (Phase 1)Looking for participantsNCT07682948What this trial is testingA Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy VolunteersWho this might be right forHypertensionDyslipidemia Korea United Pharm. Inc. 36
Not applicableStudy completedNCT01870908What this trial is testingSpecial Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis PatientsWho this might be right forRheumatoid Arthritis Astellas Pharma Inc 664
Large-scale testing (Phase 3)Study completedNCT06042049What this trial is testingAssess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of NirsevimabWho this might be right forRespiratory Syncytial Virus Infections AstraZeneca 33
Large-scale testing (Phase 3)Study completedNCT03155347What this trial is testingAn Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) TherapyWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 340
Post-approval studies (Phase 4)Ended earlyNCT01118455What this trial is testingTrial to Assess Vagus Nerve Stimulation Therapy vs. Anti-Epileptic Drug (AED) Treatment in Children With Refractory SeizuresWho this might be right forEpilepsy Cyberonics, Inc. 134
Early research (Phase 1)Study completedNCT06698926What this trial is testingAssess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult ParticipantsWho this might be right forHealthy Volunteer AbbVie 110
Testing effectiveness (Phase 2)Study completedNCT00603278What this trial is testingStudy To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.Who this might be right forAsthma GlaxoSmithKline 622
Testing effectiveness (Phase 2)Ended earlyNCT03149549What this trial is testingPROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid TumorsWho this might be right forSolid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more CytomX Therapeutics 99
Testing effectiveness (Phase 2)Looking for participantsNCT06664125What this trial is testingEvaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with HyperphosphatemiaWho this might be right forHyperphosphatemia Jemincare 50
Post-approval studies (Phase 4)Study completedNCT00977938What this trial is testingThe Dual Antiplatelet Therapy Study (DAPT Study)Who this might be right forCoronary Artery Disease Baim Institute for Clinical Research 25,682